Results 151 to 160 of about 15,555 (263)

Penetrance of pathogenic epilepsy variants is low and shaped by common genetic background

Epilepsia, EarlyView.
Abstract Objective The identification of pathogenic variants in developmental epileptic encephalopathy (DEE) genes can be vital for counseling and individualized treatment. Penetrance is usually considered to be high or full, although this has never been studied in population cohorts.
Remi Stevelink, M. Martijn Piet, Yorgos Bos, Ruben van ’t Slot, Kees P. J. Braun, Bobby P. C. Koeleman   +5 more
wiley   +1 more source

Editorial: Cardiovascular genetics—focus on paediatric cardiomyopathy

Frontiers in Pediatrics, 2023
Emanuele Monda, Juan Pablo Kaski, Giuseppe Limongelli, Giuseppe Limongelli   +3 more
doaj   +1 more source

Constrictive-effusive pericarditis and epicarditis as a cause of restrictive cardiomyopathy associated with Dirofilaria repens infection in a dog. [PDF]

BMC Vet Res
Szaluś-Jordanow O, Łobaczewski A, Jańczak D, Masny A, Kliczkowska K, Sapierzyński R, Zdeb K, Biernacka K, Gołąb E, Frymus T.   +9 more
europepmc   +1 more source

Missense Mutations in the FLNC Gene Causing Familial Restrictive Cardiomyopathy [PDF]

, 2019
Álvaro Roldan-Sevilla, Julián Palomino-Doza, Javier de Juan Bagudá, Violeta Sánchez, Cristina Domínguez‐González, Rafael Salguero‐Bodes, Fernando Arribas-Ynsaurriaga   +6 more
openalex   +1 more source

Cost‐Utility Analysis of Left Bundle Branch Area Versus Biventricular Pacing for Cardiac Resynchronization Therapy: A Multicenter, Prospective, Quasi‐Experimental Study

Journal of Cardiovascular Electrophysiology, EarlyView.
Cost‐utility of LBBAP CRT versus BVP CRT. ABSTRACT Introduction Cardiac resynchronization therapy (CRT) is a well‐established treatment for patients with heart failure (HF). Recently, left bundle branch area pacing (LBBAP) has emerged as a more physiological alternative to biventricular pacing (BVP) for CRT.
José M. Sánchez‐Moreno, Leticia García‐Mochón, Manuel Molina‐Lerma, Guillermo Gutiérrez‐Ballesteros, Manuel Frutos‐López, Ricardo Pavón‐Jiménez, M. C. Olvera‐Porcel, Juan Jiménez‐Jáimez, Miguel Álvarez   +8 more
wiley   +1 more source

Clinical-genetic profiles and risk prediction model in childhood restrictive cardiomyopathy: a national cohort study of China. [PDF]

BMC Med
Chen H, Wang S, Quan J, Ding W, Liu C, Peng H, Wang J, Xiao Y, Li Z, Wang H, Gao L, Shi L, Li Y, Yang S, Zhang L, Huang Y, Liang P, Guo Q, Li J, Shan G, Zhang H, Liu X, Zhang H, Li W, Zhang B, Zhang C, Tong S, Chan W, Wang R, Zhang H, Han L, Lv T, Fu L.   +32 more
europepmc   +1 more source

Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery. [PDF]

Cell Rep Med, 2023
Wang BZ, Nash TR, Zhang X, Rao J, Abriola L, Kim Y, Zakharov S, Kim M, Luo LJ, Morsink M, Liu B, Lock RI, Fleischer S, Tamargo MA, Bohnen M, Welch CL, Chung WK, Marx SO, Surovtseva YV, Vunjak-Novakovic G, Fine BM.   +20 more
europepmc   +1 more source

Complexity of Sarcomere Protein Gene Mutations in Restrictive Cardiomyopathy

, 2017
Shuai Wang, Daoquan Peng
openalex   +2 more sources

Navigating the Lead Paradox: Successful Co‐Implantation of Cardiac Contractility Modulation Device and a Micra Leadless Pacemaker

Journal of Cardiovascular Electrophysiology, EarlyView.
This central illustration visually summarizes the first co‐implantation of a Cardiac Contractility Modulation (CCM) system and a Micra leadless pacemaker in a 78‐year‐old male with wild‐type transthyretin cardiac amyloidosis and NYHA Class III heart failure.
Gabriele Pavani, Paolo Garrone, Gianpaolo Varalda, Antonino Previti, Matteo Bianco, Alessandra Chinaglia   +5 more
wiley   +1 more source

A case report of MYH7 mutation-induced restrictive cardiomyopathy. [PDF]

Eur Heart J Case Rep
Zhang S, Zhao W.
europepmc   +1 more source